EMIS
NASDAQEmmis Acquisition Corp.
Emmis Acquisition Corp. (EMIS) is a Biotechnology: Pharmaceutical Preparations company listed on NASDAQ. There were no new wire items for EMIS in the last 30 days. The most recent was published Sep 28, 2026.
News · 26 weeks6-100%
2026-05-102026-11-01
Mix490d
- Insider3(75%)
- SEC Filings1(25%)
Latest news
18 items- INSIDERCEO Emmis Capital Sponsor Llc disposed of 11,667 units of Class B Ordinary Shares, decreasing direct ownership by 0.30% to 3,821,666 units (SEC Form 4)4 - Emmis Acquisition Corp. (0002075816) (Issuer)
- SECEmmis Acquisition Corp. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits8-K - Emmis Acquisition Corp. (0002075816) (Filer)
- INSIDERDirector Greenberg Kenneth C. acquired 11,667 units of Class B Ordinary Shares (SEC Form 4)4 - Emmis Acquisition Corp. (0002075816) (Issuer)
- INSIDERSEC Form 3 filed by new insider Greenberg Kenneth C.3 - Emmis Acquisition Corp. (0002075816) (Issuer)
- SECSEC Form 10-Q filed by Emmis Acquisition Corp.10-Q - Emmis Acquisition Corp. (0002075816) (Filer)
- SECSEC Form 10-Q filed by Emmis Acquisition Corp.10-Q - Emmis Acquisition Corp. (0002075816) (Filer)
- SECSEC Form 10-K filed by Emmis Acquisition Corp.10-K - Emmis Acquisition Corp. (0002075816) (Filer)
- SECAmendment: SEC Form SCHEDULE 13G/A filed by Emmis Acquisition Corp.SCHEDULE 13G/A - Emmis Acquisition Corp. (0002075816) (Subject)
- SECSEC Form SCHEDULE 13G filed by Emmis Acquisition Corp.SCHEDULE 13G - Emmis Acquisition Corp. (0002075816) (Subject)
- SECAmendment: SEC Form SCHEDULE 13G/A filed by Emmis Acquisition Corp.SCHEDULE 13G/A - Emmis Acquisition Corp. (0002075816) (Subject)
- SECAmendment: SEC Form SCHEDULE 13G/A filed by Emmis Acquisition Corp.SCHEDULE 13G/A - Emmis Acquisition Corp. (0002075816) (Subject)
- PRSichenzia Ross Ference Carmel LLP Achieves Firm Record Advising on Over 170 Transactions Totaling Over $14 Billion in 2025NEW YORK, Jan. 20, 2026 (GLOBE NEWSWIRE) -- Sichenzia Ross Ference Carmel LLP ("SRFC") reported that in 2025 it advised on over 170 announced transactions, with the total value of these transactions exceeding $14 billion, far surpassing the firm's strong performance in 2024. The transactions, on behalf of various market participants, such as issuers, underwriters and investors, included initial public offerings, secondary public offerings, registered direct offerings, private placements, mergers, acquisitions and cryptocurrency transactions. In October of 2025, for the fifth consecutive quarter, SRFC was ranked first in the nation for issuer counsel among securities law firms in Placement
- SECSEC Form SCHEDULE 13G filed by Emmis Acquisition Corp.SCHEDULE 13G - Emmis Acquisition Corp. (0002075816) (Subject)
- SECSEC Form 10-Q filed by Emmis Acquisition Corp.10-Q - Emmis Acquisition Corp. (0002075816) (Filer)
- SECSEC Form SCHEDULE 13G filed by Emmis Acquisition Corp.SCHEDULE 13G - Emmis Acquisition Corp. (0002075816) (Subject)
- SECSEC Form SCHEDULE 13G filed by Emmis Acquisition Corp.SCHEDULE 13G - Emmis Acquisition Corp. (0002075816) (Subject)
- INSIDERSEC Form 3 filed by new insider Mallon-De Castro Anna Christin3 - Emmis Acquisition Corp. (0002075816) (Issuer)
- SECSEC Form 10-Q filed by Emmis Acquisition Corp.10-Q - Emmis Acquisition Corp. (0002075816) (Filer)
EMIS FAQ
6 questionsWhat is the latest news on EMIS?
Quantisnow has not tracked any new filings, ratings or press releases for EMIS in the last 30 days. The most recent wire item was published on September 28, 2026.Where does EMIS stock trade?
Emmis Acquisition Corp. (EMIS) is listed on NASDAQ.What sector and industry is EMIS in?
Emmis Acquisition Corp. operates in the Health Care sector, Biotechnology: Pharmaceutical Preparations industry.When did Emmis Acquisition Corp. go public?
Emmis Acquisition Corp. (EMIS) completed its IPO in 2025.What companies are similar to EMIS?
Notable peers in the same industry include LLY (Eli Lilly and Company), JNJ (Johnson & Johnson), ABBV (AbbVie Inc.), MRK (Merck & Company Inc.), NVS (Novartis AG). Compare EMIS side-by-side with any of them on Quantisnow.How can I track EMIS on Quantisnow?
Quantisnow aggregates Emmis Acquisition Corp.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow EMIS to receive live email and push alerts on every new disclosure.